COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,157 Articles (22,703 medRxiv, 8,454 bioRxiv)

Most recent first Previous |  Page 1362: Articles 13611-13620  | Next

Results from Canton Grisons of Switzerland Suggest Repetitive Testing Reduces SARS-CoV-2 Incidence (February-March 2021)
Gorji, H., Lunati, I., Rudolf, F., Vidondo, B., Hardt, W.-D., Jenny, P., Engel, D., Schneider, J., Jamnicki, M., Leuthold, R., Risch, L., Risch, M., Bühler, M., Sommer, A., Caduff, A.
10.1101/2021.07.13.21259739 — Posted: 2021-07-16
Epidemiology and Clinical Characteristics in Individuals with Confirmed SARS-CoV-2 Infection During the Early COVID-19 Pandemic in Saudi Arabia
Alhamlan, F. S., Almaghrabi, R. S., Devol, E. B., Alotaibi, A. B., Alageel, S. M., Obeid, D. A., Alraddadi, B. M., Althawadi, S. I., Mutabagani, M. S., Al-Qahtani, A. A.
10.1101/2021.07.13.21260428 — Posted: 2021-07-16
Combined Anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalized COVID-19 patients: a propensity matched cohort study
Matli, K., Chamoun, N., Fares, A., Zibara, V., Al-Osta, S., Nasrallah, R., Salameh, P., Mokhbat, J., Ghanem, G.
10.1101/2021.07.13.21260467 — Posted: 2021-07-16
Lessons learned and lessons missed: Impact of the Covid-19 pandemic on all-cause mortality in 40 industrialised countries prior to mass vaccination
Kontis, V., Bennett, J. E., Parks, R. M., Rashid, T., Pearson-Stuttard, J., Asaria, P., Zhou, B., Guillot, M., Mathers, C. D., Khang, Y.-H., McKee, M., Ezzati, M.
10.1101/2021.07.12.21260387 — Posted: 2021-07-16
Olfactory detection of human odorant signatures in Covid patients by trained dogs
Vlachova, L., Hotovy, G., Slechta, J., Vana, R., Vokralova, M., Zeman, J.
10.1101/2021.07.12.21258827 — Posted: 2021-07-16
Harnessing the Wisdom of the Crowd to Forecast Incident and Cumulative COVID-19 Mortality in the United States
Taylor, K. S., Taylor, J. W.
10.1101/2021.07.11.21260318 — Posted: 2021-07-16
An Open Repository of Real-Time COVID-19 Indicators
Reinhart, A., Brooks, L., Jahja, M., Rumack, A., Tang, J., Al Saeed, W., Arnold, T., Basu, A., Bien, J., Cabrera, A. A., Chin, A., Chua, E. J., Clark, B., DeFries, N., Forlizzi, J., Gratzl, S., Green, A., Haff, G., Han, R., Hu, A. J., Hyun, S., Joshi, A., Kim, J., Kuznetsov, A., La Motte-Kerr, W., Lee, Y. J., Lee, K., Lipton, Z. C., Liu, M. X., Mackey, L., Mazaitis, K., McDonald, D. J., Narasimhan, B., Oliveira, N. L., Patil, P., Perer, A., Politsch, C. A., Rajanala, S., Rucker, D., Shah, N., Shankar, V., Sharpnack, J., Shemetov, D., Simon, N., Srivastava, V., Tan, S., Tibshirani, R., Tuzhilina, E., Van Nortwick, A. K., Ventura, V., Wasserman, L., Weiss, J. C., Williams, K., Rosenfeld, R., Tibshirani, R. J.
10.1101/2021.07.12.21259660 — Posted: 2021-07-16
Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples
Lunca, C., Cojocaru, C., Gurzu, I. L., Petrariu, F. D., Cojocaru, E.
10.1101/2021.07.12.21260263 — Posted: 2021-07-16
The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings
Sheen, J. K., Haushofer, J., Metcalf, C. J. E., Kennedy-Shaffer, L.
10.1101/2021.07.12.21260375 — Posted: 2021-07-16
Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination
Minervina, A. A., Pogorelyy, M. V., Kirk, A. M., Allen, E. K., Allison, K. J., Lin, C.-Y., Brice, D. C., Zhu, X., Vegesana, K., Wu, G., Crawford, J. C., Schultz-Cherry, S., Estepp, J. H., McGargill, M., the SJTRC Study Team, , Wolf, J., Thomas, P. G.
10.1101/2021.07.12.21260227 — Posted: 2021-07-16 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).